| Synthesis, characterization and anti-cancer activity of hydrazide derivatives incorporating a quinoline moiety M Bingul, O Tan, CR Gardner, SK Sutton, GM Arndt, GM Marshall, ... Molecules 21 (7), 916, 2016 | 89 | 2016 |
| Application of Next‐Generation Sequencing (NGS) to improve cancer management: A review of the clinical effectiveness and cost‐effectiveness O Tan, R Shrestha, M Cunich, DJ Schofield Clinical Genetics, 2017 | 85* | 2017 |
| Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation M Calao, EO Sekyere, HJ Cui, BB Cheung, WD Thomas, J Keating, ... Oncogene 32 (31), 3616-3626, 2013 | 75 | 2013 |
| TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells GM Marshall, JL Bell, J Koach, O Tan, P Kim, A Malyukova, W Thomas, ... Oncogene 29 (46), 6172-6183, 2010 | 73 | 2010 |
| High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients PY Kim, O Tan, B Liu, T Trahair, T Liu, M Haber, MD Norris, GM Marshall, ... Cancer letters 374 (2), 315-323, 2016 | 51 | 2016 |
| The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation A Raif, GM Marshall, JL Bell, J Koach, O Tan, C D’andreti, W Thomas, ... Cancer letters 277 (1), 82-90, 2009 | 45 | 2009 |
| The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro BB Cheung, J Koach, O Tan, P Kim, JL Bell, C D'andreti, S Sutton, ... The Journal of pathology 226 (3), 451-462, 2012 | 43 | 2012 |
| TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells PY Kim, AS Rahmanto, O Tan, MD Norris, M Haber, GM Marshall, ... Apoptosis 18, 639-651, 2013 | 40 | 2013 |
| TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells SK Sutton, J Koach, O Tan, B Liu, DR Carter, JS Wilmott, B Yosufi, ... Oncotarget 5 (20), 10127, 2014 | 35 | 2014 |
| A brief, global history of microsimulation models in health: past applications, lessons learned and future directions DJ Schofield, MJB Zeppel, O Tan, S Lymer, MM Cunich, RN Shrestha Int. J. Microsimulation 11 (1), 97-142, 2018 | 32 | 2018 |
| Withaferin A activates TRIM16 for its anti-cancer activity in melanoma Z Nagy, BB Cheung, W Tsang, O Tan, M Herath, OC Ciampa, F Shadma, ... Scientific reports 10 (1), 19724, 2020 | 31 | 2020 |
| Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach PY Kim, O Tan, SM Diakiw, D Carter, EO Sekerye, VC Wasinger, T Liu, ... Journal of proteomics 96, 1-12, 2014 | 21 | 2014 |
| A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma BB Cheung, A Kleynhans, R Mittra, PY Kim, JK Holien, Z Nagy, ... Oncogene 40 (13), 2367-2381, 2021 | 17 | 2021 |
| Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma BB Cheung, O Tan, J Koach, B Liu, MSY Shum, DR Carter, S Sutton, ... Molecular oncology 9 (7), 1484-1500, 2015 | 17 | 2015 |
| A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner SK Sutton, DR Carter, P Kim, O Tan, GM Arndt, XD Zhang, J Baell, ... Oncotarget 7 (32), 52166, 2016 | 13 | 2016 |
| Patient-reported health-related quality of life in individuals with inherited retinal diseases D Schofield, J Kraindler, O Tan, R Shrestha, D Jelovic, S West, A Ma, ... Ophthalmology Science 2 (1), 100106, 2022 | 11 | 2022 |
| Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis SK Sutton, BB Cheung, H Massudi, O Tan, J Koach, C Mayoh, DR Carter, ... Journal of cancer research and clinical oncology 145, 2241-2250, 2019 | 10 | 2019 |
| The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study D Schofield, J Kraindler, O Tan, RN Shrestha, S West, N Hart, L Tan, A Ma, ... Medical Journal of Australia 219 (2), 70-76, 2023 | 4 | 2023 |
| Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma JA Seneviratne, DR Carter, R Mittra, A Gifford, PY Kim, JS Luo, C Mayoh, ... International Journal of Cancer 152 (7), 1399-1413, 2023 | 3 | 2023 |
| An analysis of hospital costs for childhood cancer care O Tan, DJ Schofield, R Shrestha Journal of the National Comprehensive Cancer Network 20 (2), 126-135, 2021 | 2 | 2021 |
